SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-003692
Filing Date
2016-11-09
Accepted
2016-11-09 16:01:27
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3_10Q2016.htm 10-Q 923659
2 EXHIBIT 31-1 exhibit31-1.htm EX-31.1 18137
3 EXHIBIT 31-2 exhibit31-2.htm EX-31.2 17983
4 EXHIBIT 32-1 exhibit32-1.htm EX-32.1 6605
5 EXHIBIT 32-2 exhibit32-2.htm EX-32.2 6782
  Complete submission text file 0001654954-16-003692.txt   3097922

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20160930.xml EX-101.INS 369478
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20160930.xsd EX-101.SCH 40027
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20160930_cal.xml EX-101.CAL 46535
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20160930_def.xml EX-101.DEF 123288
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20160930_lab.xml EX-101.LAB 262723
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20160930_pre.xml EX-101.PRE 194756
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 161984162
SIC: 2834 Pharmaceutical Preparations